This Mayo Clinic retrospective study examines midterm clinical and radiographic outcomes of a posterior augmented polyethylene glenoid component—designed to correct posterior glenoid bone deficiency in osteoarthritis—in 13 patients (14 shoulders) followed for a mean of 5 years after total shoulder arthroplasty.
When planning TSA for a patient with posterior glenoid bone deficiency and subluxation, recognize that neither an augmented component nor bone grafting reliably corrects instability on its own — meticulous soft-tissue balancing (capsular release, subscapularis advancement, appropriate humeral head sizing) is the critical variable, and version correction alone does not guarantee re-centering.
This Mayo Clinic retrospective study examines midterm clinical and radiographic outcomes of a posterior augmented polyethylene glenoid component—designed to correct posterior glenoid bone deficiency in osteoarthritis—in 13 patients (14 shoulders) followed for a mean of 5 years after total shoulder arthroplasty.
When planning TSA for a patient with posterior glenoid bone deficiency and subluxation, recognize that neither an augmented component nor bone grafting reliably corrects instability on its own — meticulous soft-tissue balancing (capsular release, subscapularis advancement, appropriate humeral head sizing) is the critical variable, and version correction alone does not guarantee re-centering.